Pharmaceutical industry
The latest news relating to the pharmaceuticals industry, including regulation, litigation, business news and relevant industrial and academic research, from the Royal Society of Chemistry's magazine, Chemistry World
-
FeatureOne medical inhaler can have the impact of 30kg of carbon dioxide
Propellants in asthma inhalers produce greenhouse gas emissions equivalent to driving 200 miles, yet most healthcare systems overlook this climate impact. New low-carbon alternatives are in development, Andy Extance reports, but barriers remain
-
BusinessPfizer wins bidding war for Metsera and its weight-loss drugs
US firm matched Novo Nordisk’s rival bid and had backing of competition regulator
-
BusinessPfizer and Novo Nordisk’s battle over Metsera
Lawsuits fly in bidding war over developer of next generation weight loss drugs
-
BusinessNovartis spends on deals to offset patent losses
$12 billion Avidity acquisition is the latest pipeline-pumping transaction
-
BusinessJ&J now faces talc cancer claims in the UK
Alongside nearly 70,000 US lawsuits, over 3000 claimants have filed joint UK legal action
-
ResearchThis fragment-based drug discovery library is designed to be sociable
Study targets a key bottleneck in hit to lead optimisation by designing fragments that are both structurally diverse and easy to elaborate
-
Opinion‘Making MOFs is the most fun I have ever had in the lab’
A personal connection to the 2025 Nobel prize in chemistry
-
WebinarSYNTHIA for chemists: faster route design
Join us on 11 December to discover how SYNTHIA accelerates retrosynthesis by helping chemists design, compare and refine routes with customisable filters and commercial building blocks
-
Business23 Indian children’s deaths linked to contaminated cough syrup
Dietheylene glycol contamination highlights consequences of poor inspection and enforcement
-
WebinarDeveloping a CITK protein degrader using the QuicTPD™ platform
Join us on 18 November to learn about the latest technology to accelerate the design of cancer treatments
-
OpinionKeeping tabs on contamination
Argentina’s contaminated fentanyl tragedy highlights challenges of generic drug supply
-
OpinionTrump steps up pharma tariff threat
Taxing branded drug imports could hit biotech innovators hardest
-
BusinessArvinas and Pfizer seek a new home for protein degrader drug
Companies offer bifunctional cancer drug vepdegestrant to new partners after disappointing trial results
-
BusinessNovo Nordisk’s new chief cuts 9000 jobs
Danish firm shifts strategy after struggling to capitalise on its weight loss drugs
-
OpinionIs UK pharma really ‘uninvestable’?
Merck & Co, AstraZeneca (AZ) and Eli Lilly pulling UK projects highlights the precarious position of the country’s life sciences industry
-
BusinessUK loses life sciences investment as pharma companies halt expansion plans
Industry seeks greater share of healthcare spending to support innovation
-
BusinessIndian chemist dies after methanol inhalation incident
Preliminary investigation highlights lack of protective equipment
-
WebinarIon suppression correction and normalisation in metabolomics
Join us to learn new ways to improve data consistency with mass spectrometry
-
OpinionLiver toxicity remains an unpredictable hurdle for medicinal chemists
The liver’s complex role in metabolising drugs makes it both a critical consideration and potential stumbling block
-
OpinionDeadly fentanyl contamination exposes drug safety challenges
Bacterial contamination in medical fentanyl has killed at least 51 people in Argentina, highlighting pressures on generic drugmakers